We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Drugs that prolong the QT interval may increase the risk ...

Shilpa Medicare targets US approval of 5-HT3 receptor antiemetic for chemotherapy-induced nausea and vomiting (CINV)Phase 3 study met all primary and secondary endpoints, demonstrating superior ...

In a Review published in the February 2008 issue of Nature Clinical Practice Rheumatology, Riley discussed the molecular pathology of tendinopathy and novel and specific molecular targets for therapy.

Although brainstem serotonergic (5-HT) systems are involved in the protective responses to hypoxia, abnormalities of 5-HT function are strongly implicated in SIDS, and the neurochemical mechanisms by ...

Clinical applications of hematopoietic growth factors. Comparison data used are the preclinical pharmacology as well as the design and results of clinical trials. Seven comparative studies that used ...

This is a 3-D computer model of the serotonin 5-HT3 receptor, embedded through a lipid bilayer membrane (horizontal structure with black lines and yellow balls) as it would be naturally in a cell.

Primary prophylaxis of febrile neutropenia using long-acting granulocyte colony-stimulating factors in female patients receiving dose-dense biweekly chemotherapy in the clinical routine. This is an ...

Ondansetron (as HCl dihydrate) 4mg/5mL; strawberry flavor. Ondansetron is a selective 5-HT3 receptor antagonist. Serotonin receptors of the 5-HT3 type are present both peripherally on vagal nerve ...

Shilpa Medicare targets US approval of 5-HT3 receptor antiemetic for chemotherapy-induced nausea and vomiting: Our Bureau, Bengaluru Friday, January 9, 2026, 12:15 Hrs [IST] Shilp ...